Actively Recruiting
Evaluating Night-time and Full-time Wrist Splinting Versus No Treatment for Carpal Tunnel Syndrome in a Randomized Crossover Trial
Led by Tampere University Hospital · Updated on 2026-10-05
110
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Carpal tunnel syndrome is a common nerve compression disorder in the upper limbs causing pain, numbness, and tingling in the fingers, often worse at night. The FINCROSS trial is a randomized crossover study that evaluates the effects of night-time and full-time wrist splinting compared to no treatment. It also aims to identify which patients might benefit most from splinting and whether a positive response reduces the need for surgery. Participants will undergo three treatment periods in random order wearing a wrist splint at night for six weeks, wearing the splint day and night for six weeks, and a six-week period without treatment. Each treatment phase is separated by a three-week washout period, making the full sequence 24 weeks long. Participants will also perform self-administered wrist stretching exercises throughout the study and avoid other medical interventions. During the study, participants will be assessed using symptom scales such as the 6-item CTS Symptoms Scale and the Boston Carpal Tunnel Questionnaire at baseline, mid-treatment, end of each treatment, and one year after randomization. Researchers will monitor symptom changes, quality of life, adverse effects, need for surgery, and use of escape treatments. Follow-up continues up to one year after starting the study.
CONDITIONS
Brief Title
Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome
Research Team
V
Vieda Lusa
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here